The data suggested that ERK1/2 was predominantly expressed in the cytoplasm and nucleus of tumor cells (Fig. 7B), and ERK1/2 expression in EBVnGC tissues was significantly higher than its expression in EBVaGC (Table 3). The gene discussed is MAPK3; the disease is neoplasm.